OKYO: OKYO Pharma Limited Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 47.20
Enterprise Value ($M) 47.20
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) 0.00
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 4,304 7,172 60.01
2024-04-17 905 8,681 10.43
2024-04-16 3,291 20,272 16.23
2024-04-15 3,337 3,681 90.65

(click for more detail)

Similar Companies
OCGN – Ocugen, Inc. OCUP – Ocuphire Pharma, Inc.
OCX – OncoCyte Corporation ONCO – Onconetix, Inc.
ONCT – Oncternal Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io